Ayurveda Migraine Clinic

C-15 Turner Road, Clement Town , Dehradun- 248002
Uttarakhand , India

India

+91-13526407929758509973 Fax : 1352640909 http://www.ayurvedamigraineclinic.com/

Book Appointment

Timings

Mon - Sat 9:00 AM-5:00 PM

No doctors to show

Ayurveda Migraine Clinic - Dehradun

Ayurveda Migraine Clinic introduces an Innovation towards the cause and cure of Migraine. Ayurvedic Treatment Protocol (ATP) consisting of customized diet, lifestyle and herbo mineral formulation brings sustainable relief to the migraine patients. The Ayurvedic treatment protocol is conceptualised by renowned Ayurvedic physician Vaidya Balendu Prakash, a recipient of Padamshri by President of India and a Member of International Headache Society, UK.

The experimental and clinical studies have shown that ATP for Migraine is safe and evidently effective. Ayurveda Migraine Clinic website provides general information only. It is not intended to provide instruction and you should not rely on this information to determine diagnosis, prognosis or a course of treatment. It should not be used in place of a professional consultation with a doctor.

It is based on available evidence or, where no published evidence is available, on current medical opinion and practice. Every effort is taken to ensure that the information contained in this website is accurate and complete. However, accuracy cannot be guaranteed - rapid advances in medicine may cause information contained here to become outdated, invalid or subject to debate.

Ayurveda Migraine Clinic is not responsible for the results of your decisions resulting from the use of the information, including, but not limited to, your choosing to seek or not to seek professional medical care, or from choosing or not choosing specific treatment based on the information. You should not disregard the advice of your physician or other qualified health care provider because of any information you read on this website. If you have any health care questions, please consult the relevant medical practitioner.

ATP for migraine is available at Padaav - Speciality Ayurveda Treatment Center at Dehradun through proficiently trained Ayurvedic physicians. Efforts are being made with leading institute(s) to develop this innovation masses uses following WHO guidelines. Collaborative experimental and clinical studies are in progress in association with Department of Pharmacology and Department of and Neurology at All India Institute of Medical Sciences, New Delhi.

Photo of Ayurveda Migraine Clinic

Additional Information

Chronic Migraine : Chronic migraine (CM) best characterizes those patients with a history of migraine who experience headache more than half the time.Refractory Migraine (RM) : Despite advances in headache therapies, there remains a group of sufferers with refractory (intractable, treatment - resistant) headache who fail to respond to or cannot tolerate current evidence – based treatments.

Although the concept of Refractory Headache (RH) has a long history, there have been few attempts to formalize an operational definition. The International Classification of Headache Disorders, Second Edition (ICHD - 2) does not include a definition for RH. Certain migraines are labelled as refractory, but the entity lacks a well – accepted operational definition. Efforts are now been made to reach a consensus on refractory migraine which includes – persistent and disabling migraine despite several adequate management trials.

Rebound/Medication Overuse Migraine : Analgesic agents are prescription or over-the-counter medications used to control pain including migraine and other types of headaches. When used on a daily or near daily basis, these analgesics can perpetuate the headache process. They may decrease the intensity of the pain for a few hours; however, they appear to feed into the pain system in such a way that chronic headaches may result.

Cause and Treatment : At present, there is no known etio - patho - physiology (cause) of migraine, though; various theories have been proposed by leading scientists in past decades. Similarly, there is no specific laboratory investigation for the diagnosis of migraine.

However, certain factors are known to trigger it. Common triggers of migraine include genetic and environmental factors, tyramine containing food, sulphites, nitrites and hormones. There are few other factors which might trigger attacks of migraine among individuals differently.

Specialities

Migraine is the most common primary episodic headache disorder. It is derived from Greek word ‘Hemicrania’ which means half of the head; it means a headache which affects half of the head. However, the latest understanding on migraine is as follows: Migraine is one of the varieties of recurrent headache which is not always a strictly unilateral headache; it can be bilateral and is characterized by various combinations of neurological, gastrointestinal and autonomic symptoms.

Signs and Symptoms: Accurate diagnosis of any disease is important because it has specific treatment implications. However, at present, headache diagnosis is clinical; hence there are no “gold standard” tests or biologic markers that exist for the diagnosis of migraine. In the absence of any objective parameter, the most widely used headache classification system was first developed in 1988 by International Headache Society (IHS) and revised in 2004.

Migraine has been defined as a major neurological condition among debility causing diseases by World Health Organisation. Migraine commonly starts at puberty and affects those aged between 30 – 40 years but can trouble much younger and elderly people, including children. As migraine is more troublesome at the productive years, financial cost of society, principality from lost working hours and lost productivity are incalculable.

Thus migraine brings substantial health care burden both clinically and economically to the individuals and their families. However this problem worsens when migraine converts into chronic daily headache in 4% of general population and in 22% of migraine sufferers. Around 40% of chronic migraineurs develop significant disability